100% Original Products
Fast Delivery within 24-72 Hours
Cash On Delivery Available
24/7 Order Support via whatsapp
Hypertension
Monotherapy or combination with other antihypertensives (e.g., thiazide diuretics).
Renoprotection in Type 2 Diabetes
Delays progression of renal disease in hypertensive patients with proteinuria (UACR >300 mg/g).
(Use under registered physician's guidance)
Mechanism: Selective, non-peptide angiotensin II receptor blocker (ARB). Binds reversibly to AT₁ receptors in vascular smooth muscle, adrenal glands, kidneys, and heart.
Key Actions:
Inhibits angiotensin II-induced vasoconstriction and aldosterone release.
Reduces blood pressure and glomerular pressure (renal protective effect).
| Patient Group | Regimen |
|---|---|
| Adults <75 years | Start: 50 mg once daily (max 100 mg/day) |
| Adults ≥75 years | Start: 25 mg once daily (limited data) |
| Volume-depleted * | Start: 25 mg once daily |
*Volume depletion: High-dose diuretic therapy, dehydration.
Dose adjustment interval: 2–4 weeks.
May be taken once or twice daily (split doses if >50 mg/day).
No food restrictions.
(Follow registered physician's advice)
| Drug Class | Effect | Recommendation |
|---|---|---|
| Rifampicin/Fluconazole | ↓ Active metabolite levels | Monitor efficacy; adjust dose |
| NSAIDs (e.g., Indomethacin) | ↓ Antihypertensive effect | Avoid concurrent use |
| Potassium-sparing diuretics | ↑ Hyperkalemia risk | Contraindicated |
| Aliskiren (in diabetics) | ↑ Renal impairment risk | Contraindicated |
Pregnancy (all trimesters)
Hypersensitivity to losartan
Concomitant aliskiren in diabetics
Bilateral renal artery stenosis
Common (>5%):
Dizziness • Upper respiratory infection • Headache
Mild diarrhea • Nasal congestion
Less Common:
Fatigue • Edema • Hyperkalemia • Transient renal impairment
Pregnancy (Category D):
Fetal renal damage/neonatal death risk (2nd/3rd trimesters). Discontinue immediately if pregnancy detected.
Lactation: Avoid nursing (excretion unknown; potential infant risk).
Renal Impairment:
Mild (CrCl 20–50 mL/min): No initial adjustment.
Moderate-severe (CrCl <20 mL/dialysis): Start at 25 mg/day.
Hepatic Impairment:
Cirrhosis: Start at 25 mg/day (↑ bioavailability).
Volume Depletion: Risk of symptomatic hypotension.
Hyperkalemia: Monitor serum K⁺ (especially with CKD/diabetes).
Surgery/Anesthesia: Discontinue 24h pre-procedure (hypotension risk).
Angiotensin II Receptor Blocker (ARB)
Conditions: Below 30°C; protect from light/moisture.
Keep out of children's reach.
Your email address will not be published. Required fields are marked *
Please login to write review!
Looks like there are no reviews yet.
Comment